AptarGroup (NYSE:ATR) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

AptarGroup (NYSE:ATR) issued its quarterly earnings data on Thursday. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.01, Briefing.com reports. AptarGroup had a return on equity of 15.06% and a net margin of 8.83%. The firm had revenue of $910.10 million during the quarter, compared to the consensus estimate of $930.15 million. During the same period in the previous year, the firm posted $1.23 EPS. The company’s quarterly revenue was up 1.6% compared to the same quarter last year. AptarGroup updated its Q3 2024 guidance to 1.380-1.460 EPS and its Q3 guidance to $1.38-1.46 EPS.

AptarGroup Trading Up 3.6 %

ATR traded up $5.10 during trading on Friday, hitting $146.59. The company’s stock had a trading volume of 562,787 shares, compared to its average volume of 298,512. The firm’s 50 day moving average price is $145.07 and its 200-day moving average price is $140.94. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.30 and a quick ratio of 0.89. The stock has a market cap of $9.71 billion, a PE ratio of 31.37, a PEG ratio of 3.18 and a beta of 0.57. AptarGroup has a twelve month low of $118.74 and a twelve month high of $151.73.

AptarGroup Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Thursday, July 25th will be issued a $0.45 dividend. The ex-dividend date of this dividend is Thursday, July 25th. This is an increase from AptarGroup’s previous quarterly dividend of $0.41. This represents a $1.80 annualized dividend and a yield of 1.23%. AptarGroup’s payout ratio is 35.19%.

Insider Activity

In other news, EVP Kimberly Chainey sold 825 shares of the business’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $146.77, for a total transaction of $121,085.25. Following the completion of the sale, the executive vice president now directly owns 8,812 shares of the company’s stock, valued at approximately $1,293,337.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Kimberly Chainey sold 825 shares of the business’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $146.77, for a total transaction of $121,085.25. Following the completion of the sale, the executive vice president now directly owns 8,812 shares of the company’s stock, valued at approximately $1,293,337.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Hedi Tlili sold 4,634 shares of the business’s stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $145.09, for a total transaction of $672,347.06. Following the sale, the insider now directly owns 9,379 shares of the company’s stock, valued at $1,360,799.11. The disclosure for this sale can be found here. Insiders sold 8,659 shares of company stock valued at $1,269,976 in the last ninety days. Company insiders own 1.00% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. William Blair upgraded AptarGroup from a “market perform” rating to an “outperform” rating in a research report on Monday, April 29th. Wells Fargo & Company boosted their price target on AptarGroup from $163.00 to $168.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Finally, Robert W. Baird boosted their price target on AptarGroup from $150.00 to $170.00 and gave the company an “outperform” rating in a report on Monday, April 29th.

AptarGroup Company Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.